丘脑底核脑深部电刺激术治疗泛酸激酶相关神经变性一例

doi:10.3969/j.issn.1672-6731.2022.03.015

中国现代神经疾病杂志 ›› 2022, Vol. 22 ›› Issue (3): 211-215. doi: 10.3969/j.issn.1672-6731.2022.03.015

• 病例报告 • 上一篇

2 丘脑底核脑深部电刺激术治疗泛酸激酶相关神经变性一例

吕红¹, 王军², 禹红梅¹, 阎雪晶³, 刘济源², 何志义¹

1 110001 沈阳, 中国医科大学附属第一医院神经内科;
2 110001 沈阳, 中国医科大学附属第一医院神经外科;
3 110001 沈阳, 中国医科大学附属第一医院神经电生理科

收稿日期:2021-11-08 出版日期:2022-03-25 发布日期:2022-03-31
通讯作者: 何志义,Email:hezhiyi0301@sina.com

Subthalamic nucleus deep brain stimulation in the treatment of pantothenate kinase-associated neurodegeneration: one case report

Lü Hong¹, WANG Jun², YU Hong-mei¹, YAN Xue-jing³, LIU Ji-yuan², HE Zhi-yi¹

1 Department of Neurology, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China;
2 Department of Neurosurgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China;
3 Department of Neuroelectrophysiology, The First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning, China

Received:2021-11-08 Online:2022-03-25 Published:2022-03-31

摘要/Abstract

关键词: 深部脑刺激法, 丘脑底核, 泛酸激酶相关性神经退行性疾病, 病例报告

Key words: Deep brain stimulation, Subthalamic nucleus, Pantothenate kinase-associated neurodegeneration, Case reports

吕红, 王军, 禹红梅, 阎雪晶, 刘济源, 何志义. 丘脑底核脑深部电刺激术治疗泛酸激酶相关神经变性一例[J]. 中国现代神经疾病杂志, 2022, 22(3): 211-215.

Lü Hong, WANG Jun, YU Hong-mei, YAN Xue-jing, LIU Ji-yuan, HE Zhi-yi. Subthalamic nucleus deep brain stimulation in the treatment of pantothenate kinase-associated neurodegeneration: one case report[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(3): 211-215.

http://journal11.magtechjournal.com/cjcnn/CN/Y2022/V22/I3/211

参考文献

[1] Hayflick SJ, Westaway SK, Levinson B, Zhou B, Johnson MA, Ching KH, Gitschier J. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome[J]. N Engl J Med, 2003, 348:33-40.
[2] Hogarth P, Kurian MA, Gregory A, Csányi B, Zagustin T, Kmiec T, Wood P, Klucken A, Scalise N, Sofia F, Klopstock T, Zorzi G, Nardocci N, Hayflick SJ. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN)[J]. Mol Genet Metab, 2017, 120:278-287.
[3] Hayflick SJ. Neurodegeneration with brain iron accumulation:from genes to pathogenesisρ[J]. Semin Pediatr Neurol, 2006, 13:182-185.
[4] Wang SN,Sun B,Ding N, Li S. Hallervorden-Spatz disease:3 cases report and review of literatures[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi,2014, 14:110-116.[王诗男, 孙斌, 丁楠, 李澍. Hallervorden-Spatz病:三例报告并文献复习[J]. 中国现代神经疾病杂志, 2014, 14:110-116.]
[5] Pan S, Zhu C. Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations:clinical description and a review of the literature[J]. Neurocase, 2020, 26:175-182.
[6] Li XY, Chen XW. Advances in inherited and clinical research of pantothenate kinase-associated neurodegeneration[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi,2012, 12:367-371.[李小元, 陈先文. 泛酸激酶相关性神经变性疾病遗传学与临床研究进展[J]. 中国现代神经疾病杂志, 2012, 12:367-371.]
[7] Cossu G, Abbruzzese G, Matta G, Murgia D, Melis M, Ricchi V, Galanello R, Barella S, Origa R, Balocco M, Pelosin E, Marchese R, Ruffinengo U, Forni GL. Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA):results from a four years follow-up[J]. Parkinsonism Relat Disord, 2014, 20:651-654.
[8] Woon K, Tsegaye M, Vloeberghs MH. The role of intrathecal baclofen in the management of primary and secondary dystonia in children[J]. Br J Neurosurg, 2007, 21:355-358.
[9] Castelnau P, Cif L, Valente EM, Vayssiere N, Hemm S, Gannau A, Digiorgio A, Coubes P. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration[J]. Ann Neurol, 2005, 57:738-741.
[10] Timmermann L, Pauls KA, Wieland K, Jech R, Kurlemann G, Sharma N, Gill SS, Haenggeli CA, Hayflick SJ, Hogarth P, Leenders KL, Limousin P, Malanga CJ, Moro E, Ostrem JL, Revilla FJ, Santens P, Schnitzler A, Tisch S, Valldeoriola F, Vesper J, Volkmann J, Woitalla D, Peker S. Dystonia in neurodegeneration with brain iron accumulation:outcome of bilateral pallidal stimulation[J]. Brain, 2010, 133(Pt 3):701-712.
[11] Lim BC, Ki CS, Cho A, Hwang H, Kim KJ, Hwang YS, Kim YE, Yun JY, Jeon BS, Lim YH, Paek SH, Chae JH. Pantothenate kinase-associated neurodegeneration in Korea:recurrent R440P mutation in PANK2 and outcome of deep brain stimulation[J]. Eur J Neurol, 2012, 19:556-561.
[12] De Vloo P, Lee DJ, Dallapiazza RF, Rohani M, Fasano A, Munhoz RP, Ibrahim GM, Hodaie M, Lozano AM, Kalia SK. Deep brain stimulation for pantothenate kinase-associated neurodegeneration:a meta-analysis[J]. Mov Disord, 2019, 34:264-273.
[13] Svetel M, Tomić A, Dragašević N, Petrović I, Kresojević N, Jech R, Urgošik D, Banjac I, Vitković J, Novaković I, Kostić VS. Clinical course of patients with pantothenate kinase-associated neurodegeneration (PKAN) before and after DBS surgery[J]. J Neurol, 2019, 266:2962-2969.
[14] Ge M, Zhang K, Ma Y, Meng FG, Hu WH, Yang AC, Zhang JG. Bilateral subthalamic nucleus stimulation in the treatment of neurodegeneration with brain iron accumulation type 1[J]. Stereotact Funct Neurosurg, 2011, 89:162-166.
[15] Liu Z, Liu Y, Yang Y, Wang L, Dou W, Guo J, Wang Y, Guo Y, Wan X, Ma W, Wang R. Subthalamic nuclei stimulation in patients with pantothenate kinase-associated neurodegeneration (PKAN)[J]. Neuromodulation, 2017, 20:484-491.
[16] Schjerling L, Hjermind LE, Jespersen B, Madsen FF, Brennum J, Jensen SR, Løkkegaard A, Karlsborg M. A randomized double-blind crossover trial comparing subthalamic and pallidal deep brain stimulation for dystonia[J]. J Neurosurg, 2013, 119:1537-1545.
[17] Brüggemann N, Kühn A, Schneider SA, Kamm C, Wolters A, Krause P, Moro E, Steigerwald F, Wittstock M, Tronnier V, Lozano AM, Hamani C, Poon YY, Zittel S, Wächter T, Deuschl G, Krüger R, Kupsch A, Münchau A, Lohmann K, Volkmann J, Klein C. Short-and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia[J]. Neurology, 2015, 84:895-903.
[18] Park HR, Lee JM, Ehm G, Yang HJ, Song IH, Lim YH, Kim MR, Kim KR, Lee WW, Kim YE, Hwang JH, Shin CW, Park H, Kim JW, Kim HJ, Kim C, Kim DG, Jeon BS, Paek SH. Long-term clinical outcome of internal globus pallidus deep brain stimulation for dystonia[J]. PLoS One, 2016, 11:e0146644.
[19] Grabli D, Ewenczyk C, Coelho-Braga MC, Lagrange C, Fraix V, Cornu P, Benabid AL, Vidailhet M, Pollak P. Interruption of deep brain stimulation of the globus pallidus in primary generalized dystonia[J]. Mov Disord, 2009, 24:2363-2369.
[20] Cheung T, Zhang C, Rudolph J, Alterman RL, Tagliati M. Sustained relief of generalized dystonia despite prolonged interruption of deep brain stimulation[J]. Mov Disord, 2013, 28:1431-1434.
[21] Goto S, Yamada K. Long term continuous bilateral pallidal stimulation produces stimulation independent relief of cervical dystonia[J]. J Neurol Neurosurg Psychiatry, 2004, 75:1506-1507.
[22] Hebb MO, Chiasson P, Lang AE, Brownstone RM, Mendez I. Sustained relief of dystonia following cessation of deep brain stimulation[J]. Mov Disord, 2007, 22:1958-1962.
[23] Krause M, Fogel W, Tronnier V, Pohle S, Hörtnagel K, Thyen U, Volkmann J. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration[J]. Mov Disord, 2006, 21:2255-2257.
[24] Pauls KA, Timmermann L. Deep brain stimulation in pantothenate kinase associated neurodegeneration:challenges for the future[J]. Eur J Neurol, 2012, 19:533-534.
[25] Andrews C, Aviles-Olmos I, Hariz M, Foltynie T. Which patients with dystonia benefit from deep brain stimulation:a metaregression of individual patient outcomes[J]. J Neurol Neurosurg Psychiatry, 2010, 81:1383-1389.
[26] Tomić A, Petrović I, Svetel M, Dobričić V, Dragašević Mišković N, Kostić VS. Pattern of disease progression in atypical form of pantothenate-kinase-associated neurodegeneration (PKAN)-prospective study[J]. Parkinsonism Relat Disord, 2015, 21:521-524.

选择文件类型/文献管理软件名称

选择包含的内容

2 丘脑底核脑深部电刺激术治疗泛酸激酶相关神经变性一例

Subthalamic nucleus deep brain stimulation in the treatment of pantothenate kinase-associated neurodegeneration: one case report

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	岳玲, 徐郁, 王刚. 功能性帕金森综合征一例[J]. 中国现代神经疾病杂志, 2023, 23(8): 742-744.
[2]	吴旭玲, 张安妮, 雷晓阳, 冯占辉, 王维, 贺电. 强直性肌营养不良症1型一例[J]. 中国现代神经疾病杂志, 2023, 23(8): 765-769.
[3]	潘静, 王刚. 功能性步态障碍一例[J]. 中国现代神经疾病杂志, 2023, 23(7): 610-612.
[4]	李跃文, 褚先舟, 李娟, 秦艳, 吴桐, 陈先文. BSCL2基因c.455A>G突变致远端型遗传性运动神经病V型一家系[J]. 中国现代神经疾病杂志, 2023, 23(7): 643-647.
[5]	王建, 李梦娇, 祝俊驰, 陈丽娟, 孔平. Wallenberg综合征合并高血压脑病发病的青年脑卒中一例[J]. 中国现代神经疾病杂志, 2023, 23(7): 648-651.
[6]	蒋雨锋, 黄晓琴, 周娟, 周炜, 辜强, 谭小林. 心脏黏液瘤致脑梗死一例[J]. 中国现代神经疾病杂志, 2023, 23(6): 530-534.
[7]	崔诗爽, 王刚. 功能性抽动一例[J]. 中国现代神经疾病杂志, 2023, 23(6): 539-541.
[8]	李艾青, 周东, 洪桢. 心因性非癫痫性发作两例[J]. 中国现代神经疾病杂志, 2023, 23(5): 443-446.
[9]	崔立立, 纪坤乾, 张正华, 张同霞, 赵玉英. 以排尿困难发病的SOD1基因变异致肌萎缩侧索硬化一例[J]. 中国现代神经疾病杂志, 2023, 23(5): 472-476.
[10]	杨辉, 王伟. 以进行性记忆力减退为主要表现的后部皮质萎缩一例[J]. 中国现代神经疾病杂志, 2023, 23(4): 341-345.
[11]	仲秀艳, 聂尧婷, 唐仁芸, 李艳, 吴远华, 蔡静. 克-雅病合并神经系统副肿瘤综合征一例[J]. 中国现代神经疾病杂志, 2023, 23(4): 346-350.
[12]	李娟, 李跃文, 陈先文. 成人功能性震颤一例[J]. 中国现代神经疾病杂志, 2023, 23(4): 356-358.
[13]	王梦莹, 胡峰, 舒凯, 蔡宏斌, 康慧聪. 脑深部电刺激术治疗耐药性癫痫研究进展[J]. 中国现代神经疾病杂志, 2023, 23(3): 173-178.
[14]	张玉笛, 吕瑞娟, 李娜, 张长青, 邵晓秋, 王群. 伴睡眠障碍的抗Amphiphysin抗体相关边缘叶脑炎一例[J]. 中国现代神经疾病杂志, 2023, 23(3): 233-237.
[15]	旷神怡, 张书凡, 韩翔, 杨仕林. 功能性视觉障碍一例[J]. 中国现代神经疾病杂志, 2023, 23(3): 243-246.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 丘脑底核脑深部电刺激术治疗泛酸激酶相关神经变性一例

Subthalamic nucleus deep brain stimulation in the treatment of pantothenate kinase-associated neurodegeneration: one case report

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价